Category: Equity: Multi Cap
Launch Date: 30-10-2024
Riskometer: Very High
Asset Class
Status
Open Ended Schemes
Fund Managers
Dhawal Umeshkumar Mehta, Paras Matalia
Investment Objective
The scheme seeks to generate long term capital appreciation by investing in a portfolio of equity and equity related securities of large cap, midcap and small cap companies. There is no assurance that the investment objective of the scheme will be achieved.
Benchmark
Nifty 500 Multicap 50:25:25 TRI
Expense Ratio
0.0% As on ()
Minimum Investment | Top up
0.0 | 0.0
Total Assets
0 Cr As on ()
Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.
Key Statistics | Volatility | Sharpe Ratio | Alpha | Beta | Yield to Maturity | Average Maturity |
---|---|---|---|---|---|---|
Samco Multi Cap Fund - Regular Plan - Growth | - | - | - | - | - | - |
Equity: Multi Cap | - | - | - | - | - | - |
Sector | Holdings (%) |
---|---|
N/A | 57.31 |
Pharmaceuticals & Biotechnology | 5.38 |
Industrial Products | 4.47 |
Auto Components | 3.63 |
Fertilizers & Agrochemicals | 2.38 |
Capital Markets | 2.37 |
Chemicals & Petrochemicals | 2.27 |
Electrical Equipment | 1.85 |
Automobiles | 1.71 |
Construction | 1.64 |
Company | Holdings (%) |
---|---|
Clearing Corporation of India Ltd | 54.07 |
Net Receivables / (Payables) | 3.24 |
Godawari Power And Ispat limited | 1.16 |
Saregama India Limited | 1.14 |
JB Chemicals & Pharmaceuticals Limited | 1.12 |
Engineers India Limited | 1.12 |
Apar Industries Limited | 1.12 |
Praj Industries Limited | 1.11 |
Suven Pharmaceuticals Limited | 1.11 |
360 One WAM Limited | 1.1 |